Literature DB >> 1482159

Influence of ceftriaxone on emergence of Clostridium difficile.

T Lejko-Zupanc1, J Zakelj, F Strle, M Janc, D Pleterski-Rigler.   

Abstract

The influence of long-term ceftriaxone administration on the emergence of Clostridium difficile was studied with 80 patients receiving ceftriaxone for 14 days. In five patients (6.3%) C. difficile was cultured. The appearance of gastrointestinal disturbances during treatment with ceftriaxone was common, but the rate of emergence of C. difficile in immunocompetent patients was not high.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1482159      PMCID： PMC245559          DOI： 10.1128/AAC.36.12.2850

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak.

Authors:  A Thibault; M A Miller; C Gaese
Journal:  Infect Control Hosp Epidemiol       Date:  1991-06       Impact factor: 3.254

2.  Nosocomial Clostridium difficile colonisation and disease.

Authors:  S Johnson; C R Clabots; F V Linn; M M Olson; L R Peterson; D N Gerding
Journal:  Lancet       Date:  1990-07-14       Impact factor: 79.321

3.  Epidemiology and prevention of Clostridium difficile infections in a leukemia unit.

Authors:  M Delmée; B Vandercam; V Avesani; J L Michaux
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

4.  Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery.

Authors:  G Privitera; P Scarpellini; G Ortisi; G Nicastro; R Nicolin; F de Lalla
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

5.  Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients.

Authors:  L V McFarland; C M Surawicz; W E Stamm
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

Review 6.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  1989-08-31       Impact factor: 91.245

7.  Third generation cephalosporins as a risk factor for Clostridium difficile-associated disease: a four-year survey in a general hospital.

Authors:  F de Lalla; G Privitera; G Ortisi; G Rizzardini; D Santoro; A Pagano; E Rinaldi; P Scarpellini
Journal:  J Antimicrob Chemother       Date:  1989-04       Impact factor: 5.790

Review 8.  Review of Clostridium difficile-associated diseases.

Authors:  L V McFarland; W E Stamm
Journal:  Am J Infect Control       Date:  1986-06       Impact factor: 2.918

9.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

10.  Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile.

Authors:  K H Wilson; M J Kennedy; F R Fekety
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.